Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk

Transfusion

Volumn 57, Issue 8, 2017, Pages 1875-1878

  Crowder, Lauren A ^a   Schonberger, Lawrence B ^b   Dodd, Roger Y ^a   Steele, Whitney R ^a  

^a AMERICAN RED CROSS   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD DONOR; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVOR; MALE; MIDDLE AGED; PLASMA TRANSFUSION; RECIPIENT; RISK; SURVIVOR; THROMBOCYTE TRANSFUSION; TRANSFUSION TRANSMISSION RISK; UNITED STATES; ADVERSE EFFECTS; BLOOD TRANSFUSION; CREUTZFELDT-JAKOB SYNDROME; EPIDEMIOLOGICAL MONITORING; HEALTH SURVEY; PRION DISEASE; RED CROSS; TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; CREUTZFELDT-JAKOB SYNDROME; EPIDEMIOLOGICAL MONITORING; HEALTH SURVEYS; HUMANS; MIDDLE AGED; POPULATION SURVEILLANCE; PRION DISEASES; RED CROSS;

EID: 85018318173     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14145     Document Type: Article

References (15)

1. Creutzfeldt-Jakob Disease, Classic (CJD) [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015 [cited 2016 Nov 9]. Available from: www.cdc.gov/prions/cjd
2. National Prion Disease Pathology Surveillance Center [Internet]. Cleveland (OH): Case Western Reserve University; c 2010 [cited 2016 Nov 16]. Available from: http://CJDsurveillance.com.
3. McGuire LI, Peden AH, Orrú CD, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2012;72:278-85.
4. Hewitt PE, Llewelyn CA, Mackenzie J, et al. Three reported cases of variant Creutzfeldt-Jakob disease transmission following transfusion of labile blood components. Vox Sang 2006;91:348.
5. Urwin PJ, Mackenzie JM, Llewelyn CA, et al. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study. Vox Sang 2016;110:310-6.
6. Hewitt PE, Llewelyn CA, Mackenzie J, et al. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006;91:221-30.
7. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.
8. Zou S, Fang CT, Schonberger LB. Transfusion transmission of human prion diseases. Transfus Med Rev 2008;22:58-69.
9. Dorsey K, Zou S, Schonberger LB, et al. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 2009;49:977-84.
10. Douet JY, Zafar S, Perret-Liaudet A, et al. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis 2014;20:114-7.
11. Jackson GS, Burk-Rafel J, Edgeworth JA, et al. Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol 2014;71:421-8.
12. Puopolo M, Ladogana A, Vetrugno V, et al. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion 2011;51:1556-66.
13. Molesworth AM, Mackenzie J, Everington D, et al. Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom. Transfusion 2011;51:1872-3.
14. Dorsey KA, Moritz ED, Notari EP 4th, et al. Survival of blood transfusion recipients identified by a look-back investigation. Blood Transfus 2014;12:67-72.
15. Will RG, Alpers MP, Dormont D, Schonberger LB. Infectious and sporadic prion disease. In: Prusiner SB, editor. Prion biology and diseases. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2004. p. 629-72.